60 Seconds with...

Joe Lubarsky, president, Eljay LLC
Joe Lubarsky, president, Eljay LLC

Q: In all six years of your study of Medicaid funding there have been vast payment shortfalls. What was different this year?

A: Things actually improved a little. If you look at Medicaid alone, things are probably as good as they've been. But there are no guarantees.

Q: Why did they get better?

A: State economies have improved and in 2004, 12 new states added provider taxes.

Q: How short were payments last year?

A: About $4.4 billion overall, compared to $4.6 billion the year before. That's a national average shortfall of $13.15 per patient day.

Q: How does that affect typical facilities?

A: About 92% of allowable costs were covered. It was only 89% when the economy was sluggish for a few years. But if you consider total costs and compare, that 8% shortfall is more like 11% or 12%.

Q: What has this annual study taught us?

A: Rates drive costs, not vice versa. You can't spend what you don't have. Rates the last two to three years have gone up a little more than costs. 2006 was the first time state revenues grew faster than expenditures since 1999.

Q: How does the future look?

A: Fiscal 2008 rates don't look too bad, but any change can easily change the numbers. There is no stability or predictability.

More in News

Government initiatives aim to decrease number of disabled people in nursing homes

Government initiatives aim to decrease number of disabled ...

The federal government is ramping up efforts to reduce the number of disabled people in nursing homes through interagency initiatives. While many disabled people have already been moved out of ...

Nursing home optometrist faces False Claims suit alleging excessive, unreasonable eye exams ...

An optometrist in Kentucky defrauded Medicare and Medicaid by filing claims for nursing home care that was unnecessary or not provided, alleges a False Claims Act lawsuit recently brought by the federal government.

Fecal transplants to treat C. diff now need FDA approval

The Food and Drug Administration is moving to tighten regulations around fecal transplants, which research has shown to be an effective treatment for Clostridium difficile infection.